Sesen Bio, Inc

(NASDAQ:SESN)

Latest On Sesen Bio, Inc (SESN):

Date/Time Type Description Signal Details
2023-03-08 04:52 ESTDividendA dividend of $0.36 has been announced on Mar 2, 2023. It will be paid Mar 8, 2023 with an ex-dividend date of Mar 8, 2023.Neutral
2023-03-06 04:52 ESTDividendA dividend of $0.36 has been announced on Mar 2, 2023. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 6, 2023.Neutral
2023-03-02 21:43 ESTNewsSesen Bio wins shareholder approval for Carisma mergerN/A
2023-03-02 21:43 ESTNewsSesen Bio (SESN) Investor Presentation - SlideshowN/A
2023-03-02 21:43 ESTNewsSesen Bio stockholders approve 1-for-20 reverse stock splitN/A
2023-02-28 09:34 ESTNewsSesen Bio GAAP EPS of -$0.04 beats by $0.07N/A
2023-02-14 13:22 ESTNewsSesen gains 11% on amended terms for merger with CarismaN/A
2023-01-04 23:55 ESTNewsSesen Bio board reiterates desire to merge with Carisma TherapeuticsN/A
2023-01-03 20:37 ESTNewsSesen Bio investors reiterate plan to vote against Carisma mergerN/A
2022-12-29 23:09 ESTNewsSesen Bio stock climbs 35% after hours on raised special dividend in Carisma mergerN/A
2022-11-08 00:35 ESTNewsSesen Bio GAAP EPS of $0.10, revenue of $40MN/A
2022-09-21 14:22 ESTNewsSesen Bio in merger deal with immunotherapy company Carisma TherapeuticsN/A
2022-08-09 07:52 ESTNewsSesen Bio GAAP EPS of -$0.16 misses by $0.03N/A
2022-07-27 09:41 ESTNewsSesen Bio granted additional time period for regaining complianceN/A
2022-07-18 18:10 ESTNewsHot Stocks: GS and SYF rise on Q2 earnings beat, YUM gains on upgrade, while SESN slidesN/A
2022-07-18 18:10 ESTNewsSesen Bio sheds 29% after decision to pause U.S. studies for lead assetN/A
2022-06-17 19:07 ESTNewsSesen Bio no longer seeks reverse stock split as route to regain compliance with NasdaqN/A
2022-06-07 02:06 ESTNewsInovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leaveN/A
2022-06-02 14:37 ESTNewsSesen Bio: Another Net-Net Biopharma Exploring Strategic AlternativesN/A
2022-05-09 16:36 ESTNewsSesen Bio GAAP EPS of -$0.07 beats by $0.03N/A
2022-05-03 20:24 ESTNewsSesen Bio gains on plans to explore strategic options including a saleN/A
2022-03-31 18:00 ESTNewsSesen Bio updates on resubmission plans for Vicineum marketing applicationN/A
2021-12-10 02:33 ESTNewsSesen Bio reports anticipated regulatory path forward for Vicineum, shares down 18%N/A
2021-11-26 03:39 ESTNewsSesen Bio: Interesting Price Drop After CRLN/A
2021-11-17 03:35 ESTNewsSesen Bio: Hoping For An Easy Revalidation Of Vicineum By 2022N/A
2021-11-08 18:40 ESTNewsSesen Bio EPS beats by $0.43N/A
2021-11-08 18:39 ESTNewsSesen Bio shares rise after Q3 results, cash position updateN/A
2021-11-02 03:44 ESTNewsSesen Bio shares rise after FDA Type A meeting for Vicineum in treating bladder cancerN/A
2021-10-19 17:54 ESTNewsSesen Bio granted Type A meeting by FDA for Vicineum marketing applicationN/A
2021-10-14 04:57 ESTNewsSesen Bio having best day in months as shares rise 26%N/A
2021-10-12 13:01 ESTNewsWarning: SESN is at high risk of performing badlyN/A
2021-10-06 17:33 ESTNewsSESN is at high risk of performing badlyN/A
2021-09-28 01:56 ESTNewsWarning: SESN has been downgraded to Very BearishN/A
2021-09-23 12:08 ESTNewsWarning: SESN has been downgraded to Very Bearish.N/A
2021-09-03 02:18 ESTNewsSesen Bio unveils restructuring plan after regulatory setbackN/A
2021-08-30 19:07 ESTNewsCassava Sciences joins Sesen Bio and Athira in a group hurt by tainted clinical researchN/A
2021-08-26 19:53 ESTNewsSesen withdraws EMA application for Vysyneum bladder cancer treatmentN/A
2021-08-23 15:13 ESTNewsSesen Bio: The Road AheadN/A
2021-08-21 07:19 ESTNewsPraxis tops weekly healthcare gainers; Sesen Bio joins laggards for second consecutive weekN/A
2021-08-18 17:09 ESTNewsPharmaCyte Biotech, Virpax Pharmaceuticals leads healthcare gainers; Renalytix, Sesen Bio among major losersN/A
2021-08-18 17:08 ESTNewsSesen Bio trial for cancer drug was marred by violations, undisclosed toxicity issues - StatN/A
2021-08-17 00:42 ESTNewsSesen Bio cut to neutral at H.C. Wainwright after regulatory setback for VicineumN/A
2021-08-14 16:48 ESTNewsFulcrum stock leads weekly healthcare gainers; Axsome, Sesen Bio among laggardsN/A
2021-08-13 20:46 ESTNewsFDA declines to approve Sesen Bio's Vicineum bladder cancer treatmentN/A
2021-08-13 00:18 ESTNewsSesen Bio nears a five year high ahead of key FDA decision on cancer drugN/A
2021-08-12 03:47 ESTNewsSesen Bio names John Knighton chief compliance officerN/A
2021-08-09 14:48 ESTNewsSesen Bio EPS misses by $0.09N/A
2021-08-05 13:08 ESTNewsSesen Bio inks deal with Eczacibasi for the commercialization of Vicineum in TurkeyN/A
2021-07-26 22:21 ESTNewsSesen Bio updates on commercial progress of Vicineum in U.S.N/A
2021-07-22 00:57 ESTNewsSesen Bio inks global supply partnership with Qilu PharmaceuticalN/A

About Sesen Bio, Inc (SESN):

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. The company's lead product candidates include Vicinium, a locally-administered targeted fusion protein that is in phase 3 clinical trials for the treatment of high-risk non-muscle invasive bladder cancer (NMIBC); and VB6-845d, a systemically-administered product candidate for use in the treatment of various types of EpCAM-positive solid tumors. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trials for use in the treatment of high-risk NMIBC; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

SESN Quotes by TradingView

See Advanced Chart

General

  • Name Sesen Bio, Inc
  • Symbol SESN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 25
  • Fiscal Year EndDecember
  • IPO Date2014-02-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sesenbio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 31.67
  • Price/Book (Most Recent Quarter) 5.98
  • Enterprise Value Revenue 40.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.28
  • Next Year EPS Estimate $0.05
  • Next Quarter EPS Estimate -$0.11
  • Profit Margin -199%
  • Operating Margin -287%
  • Return on Assets -17%
  • Revenue 11.24 million
  • Earnings Per Share -$1.05
  • Revenue Per Share $0.1
  • Gross Profit -17955000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 512.79 million
  • EBITDA -33451000
  • Analyst Target Price $7
  • Book Value Per Share $0.17
View More

Share Statistics

  • Shares Outstanding 167.58 million
  • Shares Float 167.48 million
  • % Held by Insiders 6%
  • % Held by Institutions 17.89%
  • Shares Short 2.37 million
  • Shares Short Prior Month 1.47 million
  • Short Ratio 0.24
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.72
  • 52 Week High $3.54
  • 52 Week Low $0.45
  • 50 Day Moving Average 2.58
  • 200 Day Moving Average 1.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sesen Bio, Inc (SESN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sesen Bio, Inc (SESN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-15$N/A-$0.11-$0.110%
2020-09-302020-11-09$11.24 million-$0.19-$0.08-137.5%
2020-06-302020-08-10$N/A-$0.24-$0.09-157.23%
2020-03-312020-05-11$N/A$0.31-$0.09457.55%
2019-12-312020-03-16$N/A-$0.32-$0.08-284.15%
2019-09-302019-11-12$N/A-$0.13-$0.09-44.44%
2019-06-302019-08-08$N/A-$0.67-$0.11-523.26%
2019-03-312019-05-10$N/A-$0.08-$0.098.57%
2018-12-312019-03-01$N/A-$0.09-$0.08-12.5%
2018-09-302018-11-08$N/A-$0.18-$0.10-89.47%
2018-06-302018-08-14$N/A-$0.16-$0.14-14.29%
2018-03-312018-05-15$N/A-$0.11-$0.1421.43%
2017-09-302017-11-17$N/A-$0.37
2017-06-302017-08-14$-425000-$0.30
2017-03-312017-05-04$425000-$0.25
2016-12-312017-03-24$825000-$0.15
2016-09-302016-11-14$28.65 million$0.91
2016-06-302016-08-12$277000-$0.33
2016-03-312016-05-05$229000-$0.39
2015-12-312016-03-24$565000-$0.53-$0.32-64.9%
2015-09-302015-11-04$67000-$0.50-$0.33-51.52%
2015-06-302015-08-13$114000-$0.36-$0.28-28.57%
2015-03-312015-04-30$244000-$0.36-$0.4723.4%
2014-12-312015-03-04$375000-$0.49-$0.35-40%
2014-09-302014-11-13$539000-$0.66-$0.43-53.49%
2014-06-302014-08-13$761000-$0.51-$0.44-15.91%
2014-03-312014-05-15$568000-$0.80-$0.39-105.13%
2013-12-312014-03-31$510000-$14.66-$0.08-18225%

Sesen Bio, Inc (SESN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sesen Bio, Inc (SESN) Chart:

Sesen Bio, Inc (SESN) News:

Below you will find a list of latest news for Sesen Bio, Inc (SESN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sesen Bio, Inc (SESN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest SESN Trades:

Date Shares Price
Jun 13, 2022 7:53 PM EST2000$0.6462
Jun 13, 2022 7:53 PM EST4500$0.6462
Jun 13, 2022 7:53 PM EST1400$0.6462
Jun 13, 2022 7:53 PM EST3019$0.6462
Jun 13, 2022 7:53 PM EST100$0.6438

Sesen Bio, Inc (SESN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000070/0001485003-20-000070-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000091957419000756/0000919574-19-000756-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000091957420000879/0000919574-20-000879-index.htm
2018-05-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1485003/000104746918004168/0001047469-18-004168-index.htm
2018-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1485003/000104746918004227/0001047469-18-004227-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000108514619000747/0001085146-19-000747-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000108514620000853/0001085146-20-000853-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000110465918037669/0001104659-18-037669-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1485003/000110465919036186/0001104659-19-036186-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000110465919036405/0001104659-19-036405-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1485003/000110465919036694/0001104659-19-036694-index.htm
2019-06-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000110465919038155/0001104659-19-038155-index.htm
2019-11-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1485003/000110465919068487/0001104659-19-068487-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000110465920013409/0001104659-20-013409-index.htm
2020-10-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1485003/000110465920120027/0001104659-20-120027-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1485003/000119312519129493/0001193125-19-129493-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000141057819000302/0001410578-19-000302-index.htm
2018-05-16S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1485003/000148500318000064/0001485003-18-000064-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000069/0001485003-18-000069-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000071/0001485003-18-000071-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000075/0001485003-18-000075-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000077/0001485003-18-000077-index.htm
2018-06-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000079/0001485003-18-000079-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000089/0001485003-18-000089-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000090/0001485003-18-000090-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000091/0001485003-18-000091-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000092/0001485003-18-000092-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000094/0001485003-18-000094-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000095/0001485003-18-000095-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000096/0001485003-18-000096-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000098/0001485003-18-000098-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000101/0001485003-18-000101-index.htm
2018-08-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000103/0001485003-18-000103-index.htm
2018-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000105/0001485003-18-000105-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500318000109/0001485003-18-000109-index.htm
2018-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000111/0001485003-18-000111-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000113/0001485003-18-000113-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000115/0001485003-18-000115-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500318000120/0001485003-18-000120-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000122/0001485003-18-000122-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500318000125/0001485003-18-000125-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000003/0001485003-19-000003-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000005/0001485003-19-000005-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000009/0001485003-19-000009-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000010/0001485003-19-000010-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000011/0001485003-19-000011-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1485003/000148500319000015/0001485003-19-000015-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000017/0001485003-19-000017-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000021/0001485003-19-000021-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000023/0001485003-19-000023-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000025/0001485003-19-000025-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500319000029/0001485003-19-000029-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000031/0001485003-19-000031-index.htm
2019-05-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000033/0001485003-19-000033-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000039/0001485003-19-000039-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000040/0001485003-19-000040-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000041/0001485003-19-000041-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000042/0001485003-19-000042-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000043/0001485003-19-000043-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000045/0001485003-19-000045-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000047/0001485003-19-000047-index.htm
2019-07-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000051/0001485003-19-000051-index.htm
2019-08-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000052/0001485003-19-000052-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000053/0001485003-19-000053-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000056/0001485003-19-000056-index.htm
2019-08-088-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000059/0001485003-19-000059-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500319000065/0001485003-19-000065-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000066/0001485003-19-000066-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000070/0001485003-19-000070-index.htm
2019-08-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000073/0001485003-19-000073-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000074/0001485003-19-000074-index.htm
2019-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000076/0001485003-19-000076-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000078/0001485003-19-000078-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000082/0001485003-19-000082-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000084/0001485003-19-000084-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000086/0001485003-19-000086-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000088/0001485003-19-000088-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500319000090/0001485003-19-000090-index.htm
2019-11-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000093/0001485003-19-000093-index.htm
2019-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000096/0001485003-19-000096-index.htm
2019-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000100/0001485003-19-000100-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000102/0001485003-19-000102-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500319000104/0001485003-19-000104-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000002/0001485003-20-000002-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000006/0001485003-20-000006-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000008/0001485003-20-000008-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000010/0001485003-20-000010-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000012/0001485003-20-000012-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000014/0001485003-20-000014-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000016/0001485003-20-000016-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000018/0001485003-20-000018-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000020/0001485003-20-000020-index.htm
2020-02-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000023/0001485003-20-000023-index.htm
2020-02-268-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000024/0001485003-20-000024-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000026/0001485003-20-000026-index.htm
2020-02-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000028/0001485003-20-000028-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000030/0001485003-20-000030-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000032/0001485003-20-000032-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000034/0001485003-20-000034-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1485003/000148500320000038/0001485003-20-000038-index.htm
2020-03-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000039/0001485003-20-000039-index.htm
2020-03-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000041/0001485003-20-000041-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000043/0001485003-20-000043-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000046/0001485003-20-000046-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000049/0001485003-20-000049-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000052/0001485003-20-000052-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000054/0001485003-20-000054-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000055/0001485003-20-000055-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000056/0001485003-20-000056-index.htm
2020-05-118-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000059/0001485003-20-000059-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000061/0001485003-20-000061-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500320000064/0001485003-20-000064-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000066/0001485003-20-000066-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000068/0001485003-20-000068-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000070/0001485003-20-000070-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000072/0001485003-20-000072-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000074/0001485003-20-000074-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000077/0001485003-20-000077-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000079/0001485003-20-000079-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000081/0001485003-20-000081-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000083/0001485003-20-000083-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1485003/000148500320000087/0001485003-20-000087-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000091/0001485003-20-000091-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000093/0001485003-20-000093-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000095/0001485003-20-000095-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000099/0001485003-20-000099-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000101/0001485003-20-000101-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000103/0001485003-20-000103-index.htm
2020-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000105/0001485003-20-000105-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000107/0001485003-20-000107-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1485003/000148500320000110/0001485003-20-000110-index.htm
2019-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1485003/000153561019000024/0001535610-19-000024-index.htm
2018-08-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000163782218000007/0001637822-18-000007-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000163782218000008/0001637822-18-000008-index.htm
2018-12-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000176073618000004/0001760736-18-000004-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000176073618000005/0001760736-18-000005-index.htm
2019-04-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1485003/000177327719000003/0001773277-19-000003-index.htm
2018-06-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1485003/999999999518001453/9999999995-18-001453-index.htm
2018-12-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1485003/999999999718009304/9999999997-18-009304-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1485003/999999999719001402/9999999997-19-001402-index.htm
2019-08-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1485003/999999999719006445/9999999997-19-006445-index.htm